Previous 10 | Next 10 |
home / stock / numif / numif news
Executive Spotlight: Marco Algorta Beramendi Title: CEO Company: Bienstar Wellness Years at current company: 1 Education profile: Marco is a storytelling businessman, with a Bachelor’s in literature (France) and a Master’s ...
Numinus to Participate in Wonderland: Miami on November 3-5, 2022 Canada NewsWire VANCOUVER, BC , Oct. 31, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treat...
Numinus Wellness ( OTCQX:NUMIF ) on Friday said it launched its Ketamine for Chronic and Serious Medical Illness Program to provide the psychedelic therapy. The program will be introduced first in Numinus' clinics in Utah, British Columbia and Quebec and the company plans ...
Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness Canada NewsWire Clinical program broadens access to ketamine-assisted therapy for an underserved population VANCOUVER, BC , Oct. 28, 2022 /CNW/ - Numinus Welln...
Summary Numinus has the potential to actively participate in a wave of consolidation that will roll through the psychedelics sector. Hype around psychedelic-assisted therapy is buffering against reality and investors are well-advised to tread cautiously. The Novamind acquisiti...
Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022 Canada NewsWire VANCOUVER, BC , Oct. 7, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care ...
A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll clinical study using the Company’s unique psychedelic molecul...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational effec...
Numinus Develops Mushroom Tea for Use in Psychedelic Research Canada NewsWire Psilocybin-containing tea bag offers substitute for whole mushrooms and other solid therapeutics VANCOUVER, B.C , Oct. 5, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus"...
Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022 Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022 Canada NewsWire VANCOUVER, BC , Sept. 29, 2022 /CNW/ - ...
News, Short Squeeze, Breakout and More Instantly...
Numinus Wellness Inc. Company Name:
NUMIF Stock Symbol:
OTCMKTS Market:
Numinus Wellness Inc. Website:
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results Canada NewsWire Q3 Fiscal 2024 Highlights Revenue of $4.3 million , a 1.9% decline over Q2 2024 Gross profit of $1.0 million , a 9.8% decline over Q2 2024 Cash position of $3.7 million ...
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024 Canada NewsWire VANCOUVER, BC , July 10, 2024 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing tradition...
Numinus Wellness Announces Resignation of Director Canada NewsWire VANCOUVER, BC , June 24, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Company ") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional a...